000142049 001__ 142049
000142049 005__ 20240229112528.0
000142049 0247_ $$2doi$$a10.1002/ijc.31862
000142049 0247_ $$2pmid$$apmid:30203838
000142049 0247_ $$2ISSN$$a0020-7136
000142049 0247_ $$2ISSN$$a1097-0215
000142049 0247_ $$2altmetric$$aaltmetric:51242603
000142049 037__ $$aDKFZ-2018-02279
000142049 041__ $$aeng
000142049 082__ $$a610
000142049 1001_ $$0P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aHoffmeister, Michael$$b0$$eFirst author$$udkfz
000142049 245__ $$aUtilization and determinants of follow-up colonoscopies within 6 years after screening colonoscopy: Prospective cohort study.
000142049 260__ $$aBognor Regis$$bWiley-Liss$$c2019
000142049 3367_ $$2DRIVER$$aarticle
000142049 3367_ $$2DataCite$$aOutput Types/Journal article
000142049 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1558078171_8973
000142049 3367_ $$2BibTeX$$aARTICLE
000142049 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000142049 3367_ $$00$$2EndNote$$aJournal Article
000142049 520__ $$aPrevious studies have reported that repeat colonoscopies were often not conducted in the recommended time interval after screening colonoscopy. We prospectively followed participants of screening colonoscopy from Germany for 6 years to investigate utilization and determinants of repeat colonoscopies. In a longitudinal study on the effectiveness of screening colonoscopy in the state of Saarland (Germany), participants who had a screening colonoscopy between 2005 and 2007 were contacted by mail 6 years after screening and requested to fill in a standardized questionnaire on utilization of repeat colonoscopies. For all colonoscopies reported, colonoscopy and histology reports were requested from the physician(s). Of 6,407 screening participants, 2,212 (35%) have utilized another colonoscopy. Among participants with negative findings at screening (no adenomas), 962 (22%) had a subsequent colonoscopy within 6 years from screening, accounting for 43% of all patients with a repeat colonoscopy. Family history of CRC and detection of hyperplastic polyps were found to be determinants of higher repeat colonoscopy use. As many as 44% of the participants with low-risk adenomas (N = 509) and 39% with high-risk adenomas (N = 290) at screening did not utilize surveillance colonoscopy within 6 years. Utilization was better with higher school education, prior cancer screening participation and if high-risk adenomas were detected, lower among current smokers and lowest among participants ≥70 years. New strategies will be required considering determinants of adherence to avoid unnecessary colonoscopies and to improve utilization of surveillance according to recommended time intervals among patients at higher risk of CRC in the future.
000142049 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000142049 588__ $$aDataset connected to CrossRef, PubMed,
000142049 7001_ $$aHolleczek, Bernd$$b1
000142049 7001_ $$0P:(DE-He78)908880209a64ea539ae8dc5fdb7e0a91$$aStock, Christian$$b2$$udkfz
000142049 7001_ $$aZwink, Nadine$$b3
000142049 7001_ $$aStolz, Thomas$$b4
000142049 7001_ $$aStegmaier, Christa$$b5
000142049 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b6$$eLast author$$udkfz
000142049 773__ $$0PERI:(DE-600)1474822-8$$a10.1002/ijc.31862$$gVol. 144, no. 2, p. 402 - 410$$n2$$p402 - 410$$tInternational journal of cancer$$v144$$x0020-7136$$y2019
000142049 909CO $$ooai:inrepo02.dkfz.de:142049$$pVDB
000142049 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000142049 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)908880209a64ea539ae8dc5fdb7e0a91$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000142049 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000142049 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000142049 9141_ $$y2019
000142049 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000142049 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000142049 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000142049 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000142049 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CANCER : 2017
000142049 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000142049 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000142049 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000142049 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000142049 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000142049 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000142049 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bINT J CANCER : 2017
000142049 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000142049 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000142049 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x2
000142049 980__ $$ajournal
000142049 980__ $$aVDB
000142049 980__ $$aI:(DE-He78)C070-20160331
000142049 980__ $$aI:(DE-He78)C120-20160331
000142049 980__ $$aI:(DE-He78)L101-20160331
000142049 980__ $$aUNRESTRICTED